AS

Abishek Sharma

Active Director Director DIN 11543327
DIN 11543327 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Abishek Sharma

Data last updated:

Abishek Sharma is a Director at Gocurex Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11543327
Primary Designation Director
Industry Pharma
First Appointment 12 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Feb 20262026Active

Board colleagues of Abishek Sharma

NameDINCompanyDesignation
Mukesh Kumar11543328Gocurex Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gocurex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abishek Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abishek Sharma

Abishek Sharma currently holds 1 directorship: Gocurex Pharmaceuticals Private Limited (Director, since 12 Feb 2026).

Abishek Sharma was first appointed on 12 Feb 2026 as Director at Gocurex Pharmaceuticals Private Limited.

The current boards of Abishek Sharma's companies include Mukesh Kumar (Gocurex Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available